RGECX
Price
$10.69
Change
+$0.04 (+0.38%)
Updated
Aug 7 closing price
Net Assets
1.86B
RWICX
Price
$70.91
Change
+$0.17 (+0.24%)
Updated
Aug 7 closing price
Net Assets
135.09B
Interact to see
Advertisement

RGECX vs RWICX

Header iconRGECX vs RWICX Comparison
Open Charts RGECX vs RWICXBanner chart's image
Russell Inv Global Equity C
Price$10.69
Change+$0.04 (+0.38%)
VolumeN/A
Net Assets1.86B
American Funds Capital World Gr&Inc R3
Price$70.91
Change+$0.17 (+0.24%)
VolumeN/A
Net Assets135.09B
RGECX vs RWICX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGECX vs. RWICX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGECX is a StrongBuy and RWICX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 135B vs. RGECX (1.86B). RWICX pays higher dividends than RGECX: RWICX (1.21) vs RGECX (0.00). RGECX was incepted earlier than RWICX: RGECX (18 years) vs RWICX (23 years). RGECX (2.01) is less costly to investors than RWICX (1.06). RGECX is a more actively managed with annual turnover of: 47.00 vs. RWICX (27.00). RGECX has a lower initial minimum investment than RWICX: RGECX (0) vs RWICX (250). RWICX annual gain was more profitable for investors over the last year : 16.03 vs. RGECX (12.18). RWICX return over 5 years is better than : 44.68 vs. RGECX (20.73).
RGECXRWICXRGECX / RWICX
Total Expense Ratio1.981.06187%
Annual Report Gross Expense Ratio2.011.06190%
Fund Existence18 years23 years-
Gain YTD10.54813.28979%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B135B1%
Annual Yield % from dividends0.001.210%
Returns for 1 year12.1816.0376%
Returns for 3 years37.7841.6091%
Returns for 5 years20.7344.6846%
Returns for 10 years-7.8856.99-14%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BOSOX17.10N/A
N/A
Boston Trust Walden Small Cap
GMVRX16.16N/A
N/A
Goldman Sachs Small/Mid Cap Equity R
MGHRX70.61N/A
N/A
Morgan Stanley Inst Growth IR
MSVMX5.21N/A
N/A
Morgan Stanley Vitality Portfolio C
CTASX38.97-0.45
-1.14%
Calamos Timpani Small Cap Growth A